About ACELYRIN, Inc. 
ACELYRIN, Inc.
Pharmaceuticals: Major
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 52 Schemes (33.03%)
Foreign Institutions
Held by 71 Foreign Institutions (14.06%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
(Quarterly Results - Mar 2025)
Net Profit:
-55 Million
Pharmaceuticals: Major
USD 229 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-1.01
-63.14%
0.56






